Triovance
Triovance is a late-preclinical stage biotechnology company transforming the treatment of diabetic foot disease. Its lead product, TRV-01, is a genetically engineered skin substitute, genetically modified to deliver insulin and VegF directly to the site of injury to enhance blood flow and improve cellular regeneration. Unlike traditional treatments, Triovance offers a low-cost, non-invasive, scalable solution that enables outpatient care to cure diabetic foot disease from within with minimal disruption to patients’ lives.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Triovance
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Triovance
2 distinct titles indexed · top 2 shown.
- 1quality manager
- 1skin-graft culture specialist
Sign up to unlock all 2 contacts at Triovance
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Triovance
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.